Craniosynostoses
15
2
3
4
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
13.3%
2 terminated out of 15 trials
66.7%
-19.8% vs benchmark
7%
1 trials in Phase 3/4
50%
2 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (15)
Neurodevelopmental Outcomes in Craniosynostosis Repair
ASO Treatment for Syndromic Craniosynostoses
Burosumab and 1-25 (OH) Vitamin D on Human Osteoblasts
Hemodynamic Monitoring During Craniosynostosis Surgery: Comparing Traditional and Newer Technology Monitors (CRASY-PRAM)
Functionalized Bioink Delivering Biomolecules for the Treatment of Craniofacial Diseases
EPBONF : Evaluation of the Safety and Effectiveness of a Medical Device Aimed at Guiding Orbito-naso-frontal Band Surgery, for the Treatment of Craniostenoses
CraNIRS Clinical Study
Clinical Feasibility Study of Preoperative Surgical Planning
Bedside Resources to Gauge Intravascular Volume Status
Craniosynostosis :Surgical Treatment Modalities and Outcome
Investigation of Anthropometric Properties of Babies With Craniosynostosis
Craniofacial Imaging With 3D MRI: an Alternative to Ionising Radiation
Myelin Imaging Changes In Patients With Neurosurgical Diseases
Scalp Block Decreases Pain and Side Effects
Blood Loss and Transfusion Requirement in Infants Treated With Tranexamic Acid